Preventing postpartum hemorrhage with misoprostol
Excessive bleeding after childbirth, or postpartum hemorrhage is the leading cause of maternal death worldwide. Rural and poor women in developing countries are particularly vulnerable: they are more likely to deliver at home far from medical services and often without skilled birth attendants. Unfortunately, women and their attendants may not be able to determine when bleeding has reached a dangerous level and emergency obstetric care may not be easily accessible.
Misoprostol, a low cost, off-patent, easy to administer drug that is stable in field conditions and greatly reduces the chance of postpartum hemorrhage. Our partner Venture Strategies Innovations works in 14 countries to Misoprostol is available to women who need it.
The Bixby Center works with Venture Strategies Innovations and local partners to demonstrate the feasibility, safety and effectiveness of community-based distribution of misoprostol to control postpartum hemorrhage after home births to provide women who cannot reach a health facility to deliver access to this life-saving technology.